Published in Hepatitis Weekly, February 6th, 2006
In the letter, Nasdaq advised the company the matter of the company's compliance with that requirement is now closed.
Genelabs is a biopharmaceutical company focused on the discovery and development of pharmaceutical products to improve human health.
Genelabs is currently concentrating its capabilities on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.